Author

@PortfolioBoss PortfolioBoss

Systematic trend-follower selling a quant strategy product with falsifiable, ticker'd calls

Posts rule-based momentum/trend-following buy and sell signa

trader score
-1.86
hit rate
20%
mean α
-1.18%
signals 14d
41

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 20% hit rate, -1.18% mean alpha, trader score -1.86. Their last-14d mentions, direction-adjusted, have moved -0.2% since posting (mean over 31 mentions with price data).

Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-08-28NVDA@PortfolioBoss+0.65Buy limit filled at $225.34 while NVDA remains in trend mode — Reports a newly filled Nvidia buy limit and continued bullish trend
2026-08-27NVDA@PortfolioBoss+0.25Notes Nvidia's first surprise day in three years and asks whether another uptrend is beginning.-4.6%
2026-08-27·@PortfolioBoss·Reports results of testing 1.2 billion strategies across stocks, ETFs and ADRs.·
2026-08-27·@PortfolioBoss·Introduces a 1.2-billion-backtest study covering over 3,000 U.S. securities.·
2026-08-26GBTC@PortfolioBoss+0.70GBTC remains on a buy signal. — Explicitly says GBTC is still rated as a buy.-1.2%
2026-08-25MNST@PortfolioBoss+0.40Constructively frames new highs and renewed trend behavior as potentially rewarding.-3.8%
2026-08-22LLY@PortfolioBoss+0.45Claims capital is flowing into Bitcoin and a broad pharmaceutical basket.-6.4%
2026-08-22PFE@PortfolioBoss+0.45Claims capital is flowing into Bitcoin and a broad pharmaceutical basket.-0.4%
2026-08-22VRTX@PortfolioBoss+0.45Claims capital is flowing into Bitcoin and a broad pharmaceutical basket.-1.2%
2026-08-22MRNA@PortfolioBoss+0.45Claims capital is flowing into Bitcoin and a broad pharmaceutical basket.-4.9%
2026-08-22BIIB@PortfolioBoss+0.45Claims capital is flowing into Bitcoin and a broad pharmaceutical basket.+0.8%
2026-08-22BTC@PortfolioBoss+0.45Claims capital is flowing into Bitcoin and a broad pharmaceutical basket.·
2026-08-22·@PortfolioBoss·Rejects volume profiles and popular chart patterns based on claimed historical backtesting.·
2026-08-22PLTR@PortfolioBoss+0.70PLTR remains on a buy signal. — Explicitly says PLTR is still on a buy and points to supporting analysis.+3.5%
2026-08-21TLT@PortfolioBoss-0.70TLT remains on a sell signal under the COT strategy. — Explicit ongoing sell signal on TLT, supported by a six-year bond bear market and COT strategy.+1.0%

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.